Stocktoria

BioScience Health Innovations, Inc. BHIC

OTC · stock · Services-Computer Processing & Data Preparation

BioScience Health Innovations, Inc. statistics & valuation

Profitability & efficiency

Net margin (%)
-245.80% -42.10% 4.70% 11.30% 2020202120222022202320242025
Gross margin (%)
86.00% 81.10% 70.90% 57.00% 2020202120222022202320242025
Operating margin (%)
-245.80% -42.10% 4.70% 12.60% 2020202120222022202320242025
Return on equity (%)
-59.90% -578.10% 10.40% 43.50% 2020202120222022202320242025
Shares outstanding
5.5M 5.5M 5.5M 5.5M 40.9M 11.0M 11.4M 2020202120222022202320242025
Net debt ($)
2020202120222022202320242025
Share buybacks ($)
2020202120222022202320242025
Return on assets (%)
-37.20% -405.60% -512.00% -539.30% -269.30% 10.00% 37.60% 2020202120222022202320242025
Free cash flow margin (%)
2020202120222022202320242025
Debt / equity (×)
2020202120222022202320242025
EPS ($)
-$0.01 $0.01 $0.06 2020202120222022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2022FY2021FY2020
Gross margin57.0%70.9%81.1%86.0%———
Operating margin12.6%4.7%-42.1%-245.8%———
Net margin11.3%4.7%-42.1%-245.8%———
Return on assets37.6%10.0%-269.3%-539.3%-512.0%-405.6%-37.2%
Return on equity43.5%10.4%3720.4%992.0%-578.1%200.2%-59.9%

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.